HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Reis Selected Research

lactacystin

10/2008A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Reis Research Topics

Disease

3Inflammation (Inflammations)
01/2017 - 06/2011
2Septic Shock (Toxic Shock Syndrome)
10/2008 - 05/2006
1Inborn Genetic Diseases (Disease, Hereditary)
11/2012
1Shock
10/2008
1Sepsis (Septicemia)
05/2006

Drug/Important Bio-Agent (IBA)

4Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017 - 05/2006
2Peptide Hydrolases (Proteases)FDA Link
01/2017 - 11/2012
2LipopolysaccharidesIBA
06/2011 - 05/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017
1Z proteaseIBA
11/2012
1Protease Inhibitors (Protease Inhibitor)IBA
11/2012
1CytokinesIBA
11/2012
1UbiquitinIBA
06/2011
1Anti-Bacterial Agents (Antibiotics)IBA
10/2008
1Proteasome InhibitorsIBA
10/2008
1lactacystinIBA
10/2008
1Toll-Like Receptor 4IBA
05/2006

Therapy/Procedure

1Therapeutics
10/2008